Operative trends and physician treatment costs associated with Dupuytren's disease in Canada
- PMID: 24497764
- PMCID: PMC3910518
Operative trends and physician treatment costs associated with Dupuytren's disease in Canada
Abstract
Purpose: To examine treatment trends and costs associated with Dupuytren's disease (DD) in Canada.
Methods: Data regarding fasciectomies, fasciotomies and digit amputations performed for DD from 2005 to 2010 were extracted from the Canadian Institute for Health Information database. The data were analyzed according to year, sex and five-year age groups. The estimated annual physician reimbursement costs for DD in Ontario were calculated using Ontario Health Insurance Plan billing information and the 2010 Physician Schedule of Benefits.
Results: The number and rate of fasciectomies remained stable from 2005 to 2009 (mean of 4067 and 1.24 per 10,000, respectively), but increased in the 2009/2010 fiscal year (to 4458 and 1.32 per 10,000). The number of fasciotomies increased from 133 in 2005/2006 to 201 in 2008/2009, but dropped to 183 in 2009/2010. The mean number of amputations remained stable (12 procedures).The ratio of males to females undergoing fasciectomies remained stable (4:1). The highest rate of fasciectomies was performed for the age groups 65 to 69 years and 70 to 74 years. Estimated mean physician remuneration for DD in Ontario remained stable ($3.2 million per annum).
Discussion: The results regarding patient demographics are comparable with results from previous literature. There was a trend toward an increasing number of fasciectomies and fasciotomies annually, with fasciotomies increasing faster than fasciectomies, which is reflective of the aging population and the recent attention to fasciotomies in the literature. The present study was the first to investigate treatment trends and physician reimbursement costs for the management of DD in Canada.
Objectif: Examiner les tendances thérapeutiques et les coûts associés à la maladie de Dupuytren (MD) au Canada.
Méthodologie: Les chercheurs ont extrait des bases de données de l’Institut canadien d’information sur la santé les données relatives aux fasciectomies, aux fasciotomies et aux amputations de doigts effectuées en raison de la MD entre 2005 et 2010. Ils ont analysé les données selon l’âge, le sexe et les groupes d’âge par tranches de cinq ans. Ils ont calculé les coûts estimatifs annuels du remboursement des médecins attribuables à la MD en Ontario, au moyen de l’information de facturation tirée du Régime d’assurance-maladie de l’Ontario et du barème des prestations des médecins pour 2010.
Résultats: Le nombre et le taux de fasciectomies sont demeurés stables de 2005 à 2009 (moyenne de 4 067 et de 1,24 sur 10 000, respectivement), mais ont augmenté pendant l’exercice 2009–2010 (à 4 458 et 1,32 sur 10 000). Le nombre de fasciotomies est passé de 133 à 2005–2006 à 201 en 2008–2009, mais a reculé à 183 en 2009–2010. Le nombre moyen d’amputations est demeuré stable (12 interventions). Le ratio d’hommes qui ont subi une fasciectomie par rapport aux femmes est également demeuré stable (4:1). Le plus fort taux de fasciectomies s’observait dans les groupes de 65 à 69 ans et de 70 à 74 ans. Enfin, la rémunération estimative moyenne des médecins pour soigner la MD en Ontario est demeurée stable (3,2 millions de dollars par année).
Exposé: Les résultats relatifs à la démographie des patients sont comparables à ceux des publications antérieures. On a constaté une tendance vers une augmentation annuelle du nombre de fasciectomies et de fasciotomies. L’augmentation des fasciotomies était plus marquée que celle des fasciectomies, ce qui reflète le vieillissement de la population et l’intérêt récent pour les fasciotomies dans les publications. La présente étude était la première à examiner les tendances en matière de traitement et les coûts du remboursement des médecins pour la prise en charge de la MD au Canada.
Keywords: Canada; Dupuytren’s disease; Fasciectomy; Fasciotomy; Physician remuneration; Treatment trends.
Figures






Similar articles
-
Comparison of Patient Demographics, Utilization Trends, and Costs of Treatment for Dupuytren's Disease in the United States From 2012 to 2019.Ann Plast Surg. 2023 Nov 1;91(5):547-552. doi: 10.1097/SAP.0000000000003665. Epub 2023 Aug 19. Ann Plast Surg. 2023. PMID: 37624871
-
Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England.BMC Musculoskelet Disord. 2011 Apr 12;12:73. doi: 10.1186/1471-2474-12-73. BMC Musculoskelet Disord. 2011. PMID: 21486483 Free PMC article.
-
The Surgical Release of Dupuytren's Contracture Using Multiple Transverse Incisions.Arch Plast Surg. 2012 Jul;39(4):426-30. doi: 10.5999/aps.2012.39.4.426. Epub 2012 Jul 13. Arch Plast Surg. 2012. PMID: 22872850 Free PMC article.
-
Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies.Bone Joint J. 2013 Aug;95-B(8):1094-100. doi: 10.1302/0301-620X.95B8.31822. Bone Joint J. 2013. PMID: 23908426 Review.
-
Trends in the Treatment of Dupuytren Disease in the United States Between 2007 and 2014.Hand (N Y). 2017 Jan;12(1):13-20. doi: 10.1177/1558944716647101. Epub 2016 May 3. Hand (N Y). 2017. PMID: 28082837 Free PMC article. Review.
Cited by
-
Real-world Medicare Healthcare Costs of Patients with Dupuytren's Contracture Treated with Collagenase or Fasciectomy.Plast Reconstr Surg Glob Open. 2022 Aug 18;10(8):e4480. doi: 10.1097/GOX.0000000000004480. eCollection 2022 Aug. Plast Reconstr Surg Glob Open. 2022. PMID: 35999874 Free PMC article.
-
Surgical fasciectomy versus collagenase injection in treating recurrent Dupuytren disease: study protocol of a randomised controlled trial.BMJ Open. 2019 Feb 25;9(2):e024424. doi: 10.1136/bmjopen-2018-024424. BMJ Open. 2019. PMID: 30808670 Free PMC article. Clinical Trial.
-
Sex Difference in the Treatment of Dupuytren's Disease: A Systematic Review and Meta-Analysis of Clinical Trials.Plast Surg (Oakv). 2024 Aug;32(3):374-383. doi: 10.1177/22925503221141707. Epub 2022 Dec 4. Plast Surg (Oakv). 2024. PMID: 39104932 Free PMC article.
-
Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands.Acta Orthop. 2019 Dec;90(6):517-522. doi: 10.1080/17453674.2019.1663472. Epub 2019 Sep 10. Acta Orthop. 2019. PMID: 31500473 Free PMC article.
References
-
- Mikkelsen OA. Dupuytren’s disease – a study of the pattern of distribution and stage of contracture in the hand. Hand. 1976;8:265–71. - PubMed
-
- Rayan GM. Clinical presentation and types of Dupuytren’s disease. Hand Clin. 1999;15:87–96. vii. - PubMed
-
- Tubiana R, Leclercq C, Hurst LC, Badalamente MA, Mackin EJ, editors. Dupuytren’s Disease. London: Martin Dunitz; 2000.
-
- Early P. Population studies in Dupuytren’s contracture. J Bone Joint Surg. 1962;44B:602–13.
LinkOut - more resources
Full Text Sources
Other Literature Sources